nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycopyrrolate—Skin disorder—Cisplatin—testicular cancer	0.00217	0.00217	CcSEcCtD
Glycopyrrolate—Hypertension—Etoposide—testicular cancer	0.00217	0.00217	CcSEcCtD
Glycopyrrolate—Pain in extremity—Doxorubicin—testicular cancer	0.00216	0.00216	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Cisplatin—testicular cancer	0.00216	0.00216	CcSEcCtD
Glycopyrrolate—Pruritus—Bleomycin—testicular cancer	0.00215	0.00215	CcSEcCtD
Glycopyrrolate—Dry skin—Epirubicin—testicular cancer	0.00214	0.00214	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Ifosfamide—testicular cancer	0.00214	0.00214	CcSEcCtD
Glycopyrrolate—Nausea—Vinblastine—testicular cancer	0.00213	0.00213	CcSEcCtD
Glycopyrrolate—Affect lability—Doxorubicin—testicular cancer	0.00213	0.00213	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.00212	0.00212	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00212	0.00212	CcSEcCtD
Glycopyrrolate—Hypotension—Cisplatin—testicular cancer	0.00209	0.00209	CcSEcCtD
Glycopyrrolate—Nasopharyngitis—Epirubicin—testicular cancer	0.00209	0.00209	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Dactinomycin—testicular cancer	0.00208	0.00208	CcSEcCtD
Glycopyrrolate—Abdominal discomfort—Methotrexate—testicular cancer	0.00207	0.00207	CcSEcCtD
Glycopyrrolate—Confusional state—Etoposide—testicular cancer	0.00206	0.00206	CcSEcCtD
Glycopyrrolate—Urticaria—Ifosfamide—testicular cancer	0.00206	0.00206	CcSEcCtD
Glycopyrrolate—Cardiac arrest—Doxorubicin—testicular cancer	0.00205	0.00205	CcSEcCtD
Glycopyrrolate—Abdominal pain—Ifosfamide—testicular cancer	0.00205	0.00205	CcSEcCtD
Glycopyrrolate—Body temperature increased—Ifosfamide—testicular cancer	0.00205	0.00205	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Etoposide—testicular cancer	0.00205	0.00205	CcSEcCtD
Glycopyrrolate—Mood swings—Doxorubicin—testicular cancer	0.00205	0.00205	CcSEcCtD
Glycopyrrolate—Infection—Etoposide—testicular cancer	0.00203	0.00203	CcSEcCtD
Glycopyrrolate—Abdominal distension—Epirubicin—testicular cancer	0.00203	0.00203	CcSEcCtD
Glycopyrrolate—Asthenia—Dactinomycin—testicular cancer	0.00203	0.00203	CcSEcCtD
Glycopyrrolate—Dysuria—Methotrexate—testicular cancer	0.00202	0.00202	CcSEcCtD
Glycopyrrolate—Dehydration—Doxorubicin—testicular cancer	0.00201	0.00201	CcSEcCtD
Glycopyrrolate—Upper respiratory tract infection—Methotrexate—testicular cancer	0.002	0.002	CcSEcCtD
Glycopyrrolate—Tachycardia—Etoposide—testicular cancer	0.002	0.002	CcSEcCtD
Glycopyrrolate—Skin disorder—Etoposide—testicular cancer	0.00199	0.00199	CcSEcCtD
Glycopyrrolate—Erectile dysfunction—Methotrexate—testicular cancer	0.00199	0.00199	CcSEcCtD
Glycopyrrolate—Dry skin—Doxorubicin—testicular cancer	0.00198	0.00198	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Etoposide—testicular cancer	0.00198	0.00198	CcSEcCtD
Glycopyrrolate—Pneumonia—Methotrexate—testicular cancer	0.00193	0.00193	CcSEcCtD
Glycopyrrolate—Nasopharyngitis—Doxorubicin—testicular cancer	0.00193	0.00193	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00193	0.00193	CcSEcCtD
Glycopyrrolate—Vomiting—Bleomycin—testicular cancer	0.00193	0.00193	CcSEcCtD
Glycopyrrolate—Infestation NOS—Methotrexate—testicular cancer	0.00192	0.00192	CcSEcCtD
Glycopyrrolate—Infestation—Methotrexate—testicular cancer	0.00192	0.00192	CcSEcCtD
Glycopyrrolate—Drowsiness—Methotrexate—testicular cancer	0.00192	0.00192	CcSEcCtD
Glycopyrrolate—Hypotension—Etoposide—testicular cancer	0.00191	0.00191	CcSEcCtD
Glycopyrrolate—Rash—Bleomycin—testicular cancer	0.00191	0.00191	CcSEcCtD
Glycopyrrolate—Pain—Cisplatin—testicular cancer	0.00191	0.00191	CcSEcCtD
Glycopyrrolate—Dermatitis—Bleomycin—testicular cancer	0.00191	0.00191	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Ifosfamide—testicular cancer	0.00191	0.00191	CcSEcCtD
Glycopyrrolate—Dysuria—Epirubicin—testicular cancer	0.00189	0.00189	CcSEcCtD
Glycopyrrolate—Abdominal distension—Doxorubicin—testicular cancer	0.00188	0.00188	CcSEcCtD
Glycopyrrolate—Upper respiratory tract infection—Epirubicin—testicular cancer	0.00188	0.00188	CcSEcCtD
Glycopyrrolate—Asthenia—Ifosfamide—testicular cancer	0.00186	0.00186	CcSEcCtD
Glycopyrrolate—Sweating—Methotrexate—testicular cancer	0.00184	0.00184	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Cisplatin—testicular cancer	0.00184	0.00184	CcSEcCtD
Glycopyrrolate—Pruritus—Ifosfamide—testicular cancer	0.00183	0.00183	CcSEcCtD
Glycopyrrolate—Hyperglycaemia—Epirubicin—testicular cancer	0.00182	0.00182	CcSEcCtD
Glycopyrrolate—Somnolence—Etoposide—testicular cancer	0.00182	0.00182	CcSEcCtD
Glycopyrrolate—Epistaxis—Methotrexate—testicular cancer	0.00181	0.00181	CcSEcCtD
Glycopyrrolate—Pneumonia—Epirubicin—testicular cancer	0.00181	0.00181	CcSEcCtD
Glycopyrrolate—Nausea—Bleomycin—testicular cancer	0.0018	0.0018	CcSEcCtD
Glycopyrrolate—Infestation NOS—Epirubicin—testicular cancer	0.0018	0.0018	CcSEcCtD
Glycopyrrolate—Infestation—Epirubicin—testicular cancer	0.0018	0.0018	CcSEcCtD
Glycopyrrolate—Drowsiness—Epirubicin—testicular cancer	0.0018	0.0018	CcSEcCtD
Glycopyrrolate—Vomiting—Dactinomycin—testicular cancer	0.0018	0.0018	CcSEcCtD
Glycopyrrolate—Rash—Dactinomycin—testicular cancer	0.00178	0.00178	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Etoposide—testicular cancer	0.00177	0.00177	CcSEcCtD
Glycopyrrolate—Body temperature increased—Cisplatin—testicular cancer	0.00177	0.00177	CcSEcCtD
Glycopyrrolate—Fatigue—Etoposide—testicular cancer	0.00176	0.00176	CcSEcCtD
Glycopyrrolate—Pain—Etoposide—testicular cancer	0.00175	0.00175	CcSEcCtD
Glycopyrrolate—Constipation—Etoposide—testicular cancer	0.00175	0.00175	CcSEcCtD
Glycopyrrolate—Urinary tract infection—Epirubicin—testicular cancer	0.00175	0.00175	CcSEcCtD
Glycopyrrolate—Dysuria—Doxorubicin—testicular cancer	0.00175	0.00175	CcSEcCtD
Glycopyrrolate—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.00174	0.00174	CcSEcCtD
Glycopyrrolate—Sweating—Epirubicin—testicular cancer	0.00172	0.00172	CcSEcCtD
Glycopyrrolate—Dizziness—Ifosfamide—testicular cancer	0.00171	0.00171	CcSEcCtD
Glycopyrrolate—Urinary tract disorder—Methotrexate—testicular cancer	0.0017	0.0017	CcSEcCtD
Glycopyrrolate—Epistaxis—Epirubicin—testicular cancer	0.0017	0.0017	CcSEcCtD
Glycopyrrolate—Urethral disorder—Methotrexate—testicular cancer	0.00169	0.00169	CcSEcCtD
Glycopyrrolate—Sinusitis—Epirubicin—testicular cancer	0.00169	0.00169	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Etoposide—testicular cancer	0.00169	0.00169	CcSEcCtD
Glycopyrrolate—Hyperglycaemia—Doxorubicin—testicular cancer	0.00168	0.00168	CcSEcCtD
Glycopyrrolate—Nausea—Dactinomycin—testicular cancer	0.00168	0.00168	CcSEcCtD
Glycopyrrolate—Pneumonia—Doxorubicin—testicular cancer	0.00167	0.00167	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Etoposide—testicular cancer	0.00167	0.00167	CcSEcCtD
Glycopyrrolate—Drowsiness—Doxorubicin—testicular cancer	0.00166	0.00166	CcSEcCtD
Glycopyrrolate—Infestation NOS—Doxorubicin—testicular cancer	0.00166	0.00166	CcSEcCtD
Glycopyrrolate—Infestation—Doxorubicin—testicular cancer	0.00166	0.00166	CcSEcCtD
Glycopyrrolate—Vomiting—Ifosfamide—testicular cancer	0.00165	0.00165	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Cisplatin—testicular cancer	0.00165	0.00165	CcSEcCtD
Glycopyrrolate—Rash—Ifosfamide—testicular cancer	0.00163	0.00163	CcSEcCtD
Glycopyrrolate—Dermatitis—Ifosfamide—testicular cancer	0.00163	0.00163	CcSEcCtD
Glycopyrrolate—Urticaria—Etoposide—testicular cancer	0.00163	0.00163	CcSEcCtD
Glycopyrrolate—Rhinitis—Epirubicin—testicular cancer	0.00162	0.00162	CcSEcCtD
Glycopyrrolate—Body temperature increased—Etoposide—testicular cancer	0.00162	0.00162	CcSEcCtD
Glycopyrrolate—Abdominal pain—Etoposide—testicular cancer	0.00162	0.00162	CcSEcCtD
Glycopyrrolate—Urinary tract infection—Doxorubicin—testicular cancer	0.00162	0.00162	CcSEcCtD
Glycopyrrolate—Hypoaesthesia—Epirubicin—testicular cancer	0.00161	0.00161	CcSEcCtD
Glycopyrrolate—Asthenia—Cisplatin—testicular cancer	0.0016	0.0016	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Methotrexate—testicular cancer	0.0016	0.0016	CcSEcCtD
Glycopyrrolate—Sweating—Doxorubicin—testicular cancer	0.0016	0.0016	CcSEcCtD
Glycopyrrolate—Urinary tract disorder—Epirubicin—testicular cancer	0.00159	0.00159	CcSEcCtD
Glycopyrrolate—Connective tissue disorder—Epirubicin—testicular cancer	0.00159	0.00159	CcSEcCtD
Glycopyrrolate—Urethral disorder—Epirubicin—testicular cancer	0.00158	0.00158	CcSEcCtD
Glycopyrrolate—Epistaxis—Doxorubicin—testicular cancer	0.00157	0.00157	CcSEcCtD
Glycopyrrolate—Sinusitis—Doxorubicin—testicular cancer	0.00156	0.00156	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Methotrexate—testicular cancer	0.00156	0.00156	CcSEcCtD
Glycopyrrolate—Nausea—Ifosfamide—testicular cancer	0.00154	0.00154	CcSEcCtD
Glycopyrrolate—Mental disorder—Methotrexate—testicular cancer	0.00151	0.00151	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Etoposide—testicular cancer	0.00151	0.00151	CcSEcCtD
Glycopyrrolate—Malnutrition—Methotrexate—testicular cancer	0.0015	0.0015	CcSEcCtD
Glycopyrrolate—Erythema—Methotrexate—testicular cancer	0.0015	0.0015	CcSEcCtD
Glycopyrrolate—Flushing—Epirubicin—testicular cancer	0.0015	0.0015	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Epirubicin—testicular cancer	0.0015	0.0015	CcSEcCtD
Glycopyrrolate—Rhinitis—Doxorubicin—testicular cancer	0.0015	0.0015	CcSEcCtD
Glycopyrrolate—Hypoaesthesia—Doxorubicin—testicular cancer	0.00149	0.00149	CcSEcCtD
Glycopyrrolate—Urinary tract disorder—Doxorubicin—testicular cancer	0.00148	0.00148	CcSEcCtD
Glycopyrrolate—Dysgeusia—Methotrexate—testicular cancer	0.00147	0.00147	CcSEcCtD
Glycopyrrolate—Asthenia—Etoposide—testicular cancer	0.00147	0.00147	CcSEcCtD
Glycopyrrolate—Connective tissue disorder—Doxorubicin—testicular cancer	0.00147	0.00147	CcSEcCtD
Glycopyrrolate—Urethral disorder—Doxorubicin—testicular cancer	0.00146	0.00146	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Epirubicin—testicular cancer	0.00146	0.00146	CcSEcCtD
Glycopyrrolate—Pruritus—Etoposide—testicular cancer	0.00145	0.00145	CcSEcCtD
Glycopyrrolate—Vomiting—Cisplatin—testicular cancer	0.00142	0.00142	CcSEcCtD
Glycopyrrolate—Vision blurred—Methotrexate—testicular cancer	0.00142	0.00142	CcSEcCtD
Glycopyrrolate—Mental disorder—Epirubicin—testicular cancer	0.00141	0.00141	CcSEcCtD
Glycopyrrolate—Rash—Cisplatin—testicular cancer	0.00141	0.00141	CcSEcCtD
Glycopyrrolate—Dermatitis—Cisplatin—testicular cancer	0.00141	0.00141	CcSEcCtD
Glycopyrrolate—Erythema—Epirubicin—testicular cancer	0.00141	0.00141	CcSEcCtD
Glycopyrrolate—Malnutrition—Epirubicin—testicular cancer	0.00141	0.00141	CcSEcCtD
Glycopyrrolate—Flushing—Doxorubicin—testicular cancer	0.00139	0.00139	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Doxorubicin—testicular cancer	0.00139	0.00139	CcSEcCtD
Glycopyrrolate—Flatulence—Epirubicin—testicular cancer	0.00139	0.00139	CcSEcCtD
Glycopyrrolate—Tension—Epirubicin—testicular cancer	0.00138	0.00138	CcSEcCtD
Glycopyrrolate—Dysgeusia—Epirubicin—testicular cancer	0.00138	0.00138	CcSEcCtD
Glycopyrrolate—Nervousness—Epirubicin—testicular cancer	0.00137	0.00137	CcSEcCtD
Glycopyrrolate—Dizziness—Etoposide—testicular cancer	0.00135	0.00135	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Doxorubicin—testicular cancer	0.00135	0.00135	CcSEcCtD
Glycopyrrolate—Nausea—Cisplatin—testicular cancer	0.00133	0.00133	CcSEcCtD
Glycopyrrolate—Vision blurred—Epirubicin—testicular cancer	0.00132	0.00132	CcSEcCtD
Glycopyrrolate—Mental disorder—Doxorubicin—testicular cancer	0.00131	0.00131	CcSEcCtD
Glycopyrrolate—Convulsion—Methotrexate—testicular cancer	0.0013	0.0013	CcSEcCtD
Glycopyrrolate—Vomiting—Etoposide—testicular cancer	0.0013	0.0013	CcSEcCtD
Glycopyrrolate—Erythema—Doxorubicin—testicular cancer	0.0013	0.0013	CcSEcCtD
Glycopyrrolate—Malnutrition—Doxorubicin—testicular cancer	0.0013	0.0013	CcSEcCtD
Glycopyrrolate—Agitation—Epirubicin—testicular cancer	0.00129	0.00129	CcSEcCtD
Glycopyrrolate—Rash—Etoposide—testicular cancer	0.00129	0.00129	CcSEcCtD
Glycopyrrolate—Dermatitis—Etoposide—testicular cancer	0.00129	0.00129	CcSEcCtD
Glycopyrrolate—Headache—Etoposide—testicular cancer	0.00128	0.00128	CcSEcCtD
Glycopyrrolate—Flatulence—Doxorubicin—testicular cancer	0.00128	0.00128	CcSEcCtD
Glycopyrrolate—Tension—Doxorubicin—testicular cancer	0.00128	0.00128	CcSEcCtD
Glycopyrrolate—Dysgeusia—Doxorubicin—testicular cancer	0.00127	0.00127	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.00127	0.00127	CcSEcCtD
Glycopyrrolate—Nervousness—Doxorubicin—testicular cancer	0.00126	0.00126	CcSEcCtD
Glycopyrrolate—Palpitations—Epirubicin—testicular cancer	0.00124	0.00124	CcSEcCtD
Glycopyrrolate—Confusional state—Methotrexate—testicular cancer	0.00124	0.00124	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Methotrexate—testicular cancer	0.00123	0.00123	CcSEcCtD
Glycopyrrolate—Vision blurred—Doxorubicin—testicular cancer	0.00123	0.00123	CcSEcCtD
Glycopyrrolate—Convulsion—Epirubicin—testicular cancer	0.00122	0.00122	CcSEcCtD
Glycopyrrolate—Infection—Methotrexate—testicular cancer	0.00122	0.00122	CcSEcCtD
Glycopyrrolate—Nausea—Etoposide—testicular cancer	0.00122	0.00122	CcSEcCtD
Glycopyrrolate—Hypertension—Epirubicin—testicular cancer	0.00121	0.00121	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Methotrexate—testicular cancer	0.0012	0.0012	CcSEcCtD
Glycopyrrolate—Agitation—Doxorubicin—testicular cancer	0.0012	0.0012	CcSEcCtD
Glycopyrrolate—Skin disorder—Methotrexate—testicular cancer	0.00119	0.00119	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.00119	0.00119	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Methotrexate—testicular cancer	0.00119	0.00119	CcSEcCtD
Glycopyrrolate—Dry mouth—Epirubicin—testicular cancer	0.00117	0.00117	CcSEcCtD
Glycopyrrolate—Confusional state—Epirubicin—testicular cancer	0.00116	0.00116	CcSEcCtD
Glycopyrrolate—Palpitations—Doxorubicin—testicular cancer	0.00115	0.00115	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Epirubicin—testicular cancer	0.00115	0.00115	CcSEcCtD
Glycopyrrolate—Oedema—Epirubicin—testicular cancer	0.00115	0.00115	CcSEcCtD
Glycopyrrolate—Hypotension—Methotrexate—testicular cancer	0.00115	0.00115	CcSEcCtD
Glycopyrrolate—Infection—Epirubicin—testicular cancer	0.00114	0.00114	CcSEcCtD
Glycopyrrolate—Convulsion—Doxorubicin—testicular cancer	0.00113	0.00113	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Epirubicin—testicular cancer	0.00113	0.00113	CcSEcCtD
Glycopyrrolate—Hypertension—Doxorubicin—testicular cancer	0.00112	0.00112	CcSEcCtD
Glycopyrrolate—Tachycardia—Epirubicin—testicular cancer	0.00112	0.00112	CcSEcCtD
Glycopyrrolate—Skin disorder—Epirubicin—testicular cancer	0.00111	0.00111	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Epirubicin—testicular cancer	0.00111	0.00111	CcSEcCtD
Glycopyrrolate—Insomnia—Methotrexate—testicular cancer	0.00111	0.00111	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.0011	0.0011	CcSEcCtD
Glycopyrrolate—Somnolence—Methotrexate—testicular cancer	0.00109	0.00109	CcSEcCtD
Glycopyrrolate—Dry mouth—Doxorubicin—testicular cancer	0.00108	0.00108	CcSEcCtD
Glycopyrrolate—Dyspepsia—Methotrexate—testicular cancer	0.00108	0.00108	CcSEcCtD
Glycopyrrolate—Hypotension—Epirubicin—testicular cancer	0.00107	0.00107	CcSEcCtD
Glycopyrrolate—Confusional state—Doxorubicin—testicular cancer	0.00107	0.00107	CcSEcCtD
Glycopyrrolate—Oedema—Doxorubicin—testicular cancer	0.00106	0.00106	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Doxorubicin—testicular cancer	0.00106	0.00106	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Methotrexate—testicular cancer	0.00106	0.00106	CcSEcCtD
Glycopyrrolate—Fatigue—Methotrexate—testicular cancer	0.00106	0.00106	CcSEcCtD
Glycopyrrolate—Infection—Doxorubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Glycopyrrolate—Pain—Methotrexate—testicular cancer	0.00105	0.00105	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Doxorubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Glycopyrrolate—Insomnia—Epirubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Glycopyrrolate—Tachycardia—Doxorubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Glycopyrrolate—Skin disorder—Doxorubicin—testicular cancer	0.00103	0.00103	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Doxorubicin—testicular cancer	0.00103	0.00103	CcSEcCtD
Glycopyrrolate—Somnolence—Epirubicin—testicular cancer	0.00102	0.00102	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Methotrexate—testicular cancer	0.00101	0.00101	CcSEcCtD
Glycopyrrolate—Dyspepsia—Epirubicin—testicular cancer	0.00101	0.00101	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Methotrexate—testicular cancer	0.001	0.001	CcSEcCtD
Glycopyrrolate—Hypotension—Doxorubicin—testicular cancer	0.000992	0.000992	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000991	0.000991	CcSEcCtD
Glycopyrrolate—Fatigue—Epirubicin—testicular cancer	0.000989	0.000989	CcSEcCtD
Glycopyrrolate—Constipation—Epirubicin—testicular cancer	0.000981	0.000981	CcSEcCtD
Glycopyrrolate—Pain—Epirubicin—testicular cancer	0.000981	0.000981	CcSEcCtD
Glycopyrrolate—Urticaria—Methotrexate—testicular cancer	0.000974	0.000974	CcSEcCtD
Glycopyrrolate—Abdominal pain—Methotrexate—testicular cancer	0.000969	0.000969	CcSEcCtD
Glycopyrrolate—Body temperature increased—Methotrexate—testicular cancer	0.000969	0.000969	CcSEcCtD
Glycopyrrolate—Insomnia—Doxorubicin—testicular cancer	0.00096	0.00096	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Epirubicin—testicular cancer	0.000946	0.000946	CcSEcCtD
Glycopyrrolate—Somnolence—Doxorubicin—testicular cancer	0.000944	0.000944	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Epirubicin—testicular cancer	0.000938	0.000938	CcSEcCtD
Glycopyrrolate—Dyspepsia—Doxorubicin—testicular cancer	0.000935	0.000935	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000917	0.000917	CcSEcCtD
Glycopyrrolate—Fatigue—Doxorubicin—testicular cancer	0.000915	0.000915	CcSEcCtD
Glycopyrrolate—Urticaria—Epirubicin—testicular cancer	0.000912	0.000912	CcSEcCtD
Glycopyrrolate—Pain—Doxorubicin—testicular cancer	0.000908	0.000908	CcSEcCtD
Glycopyrrolate—Constipation—Doxorubicin—testicular cancer	0.000908	0.000908	CcSEcCtD
Glycopyrrolate—Body temperature increased—Epirubicin—testicular cancer	0.000907	0.000907	CcSEcCtD
Glycopyrrolate—Abdominal pain—Epirubicin—testicular cancer	0.000907	0.000907	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Methotrexate—testicular cancer	0.000903	0.000903	CcSEcCtD
Glycopyrrolate—Asthenia—Methotrexate—testicular cancer	0.00088	0.00088	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Doxorubicin—testicular cancer	0.000875	0.000875	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000868	0.000868	CcSEcCtD
Glycopyrrolate—Pruritus—Methotrexate—testicular cancer	0.000867	0.000867	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Epirubicin—testicular cancer	0.000845	0.000845	CcSEcCtD
Glycopyrrolate—Urticaria—Doxorubicin—testicular cancer	0.000843	0.000843	CcSEcCtD
Glycopyrrolate—Abdominal pain—Doxorubicin—testicular cancer	0.000839	0.000839	CcSEcCtD
Glycopyrrolate—Body temperature increased—Doxorubicin—testicular cancer	0.000839	0.000839	CcSEcCtD
Glycopyrrolate—Asthenia—Epirubicin—testicular cancer	0.000823	0.000823	CcSEcCtD
Glycopyrrolate—Pruritus—Epirubicin—testicular cancer	0.000812	0.000812	CcSEcCtD
Glycopyrrolate—Dizziness—Methotrexate—testicular cancer	0.000811	0.000811	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Doxorubicin—testicular cancer	0.000782	0.000782	CcSEcCtD
Glycopyrrolate—Vomiting—Methotrexate—testicular cancer	0.00078	0.00078	CcSEcCtD
Glycopyrrolate—Rash—Methotrexate—testicular cancer	0.000773	0.000773	CcSEcCtD
Glycopyrrolate—Dermatitis—Methotrexate—testicular cancer	0.000772	0.000772	CcSEcCtD
Glycopyrrolate—Headache—Methotrexate—testicular cancer	0.000768	0.000768	CcSEcCtD
Glycopyrrolate—Asthenia—Doxorubicin—testicular cancer	0.000762	0.000762	CcSEcCtD
Glycopyrrolate—Dizziness—Epirubicin—testicular cancer	0.000759	0.000759	CcSEcCtD
Glycopyrrolate—Pruritus—Doxorubicin—testicular cancer	0.000751	0.000751	CcSEcCtD
Glycopyrrolate—Vomiting—Epirubicin—testicular cancer	0.00073	0.00073	CcSEcCtD
Glycopyrrolate—Nausea—Methotrexate—testicular cancer	0.000728	0.000728	CcSEcCtD
Glycopyrrolate—Rash—Epirubicin—testicular cancer	0.000723	0.000723	CcSEcCtD
Glycopyrrolate—Dermatitis—Epirubicin—testicular cancer	0.000723	0.000723	CcSEcCtD
Glycopyrrolate—Headache—Epirubicin—testicular cancer	0.000719	0.000719	CcSEcCtD
Glycopyrrolate—Dizziness—Doxorubicin—testicular cancer	0.000702	0.000702	CcSEcCtD
Glycopyrrolate—Nausea—Epirubicin—testicular cancer	0.000682	0.000682	CcSEcCtD
Glycopyrrolate—Vomiting—Doxorubicin—testicular cancer	0.000675	0.000675	CcSEcCtD
Glycopyrrolate—Rash—Doxorubicin—testicular cancer	0.000669	0.000669	CcSEcCtD
Glycopyrrolate—Dermatitis—Doxorubicin—testicular cancer	0.000669	0.000669	CcSEcCtD
Glycopyrrolate—Headache—Doxorubicin—testicular cancer	0.000665	0.000665	CcSEcCtD
Glycopyrrolate—Nausea—Doxorubicin—testicular cancer	0.000631	0.000631	CcSEcCtD
